Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

20151,134 citationsJournal Articlebronze Open Access

Authors

Esther González-López · Hospital Universitario Puerta de Hierro Majadahonda

María Gallego‐Delgado · Hospital Universitario Puerta de Hierro Majadahonda

Gonzalo Guzzo-Merello · Hospital Universitario Puerta de Hierro Majadahonda

F. Javier de Haro-del Moral · Hospital Universitario Puerta de Hierro Majadahonda

Marta Cobo Marcos · Hospital Universitario Puerta de Hierro Majadahonda

Carolina Casado Robles · Hospital Universitario Puerta de Hierro Majadahonda

Abstract

ATTRwt is an underdiagnosed disease that accounts for a significant number (13%) of HFpEF cases. The effect of emerging TTR-modifying drugs should be evaluated in these patients.

Topics & Keywords

Amyloidosis: Diagnosis, Treatment, Outcomes Cardiomyopathy and Myosin Studies Parathyroid Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 36, Issue 38, pp. 2585-2594

DOI: 10.1093/eurheartj/ehv338

Field-Weighted Citation Impact: 20.38